Serina Therapeutics Inc (SER)
8.14
-0.66
(-7.50%)
USD |
NYAM |
May 10, 16:00
8.65
+0.51
(+6.27%)
After-Hours: 20:00
Serina Therapeutics Shareholders Equity (Quarterly): -35.29M for June 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2023 | -35.29M |
June 30, 2023 | -35.29M |
Date | Value |
---|---|
December 31, 2022 | -37.78M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-37.78M
Minimum
Dec 2022
-35.29M
Maximum
Jun 2023
-36.12M
Average
-35.29M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
CEL-SCI Corp | 12.65M |
AIM ImmunoTech Inc | 10.23M |
IGC Pharma Inc | 9.053M |
NovaBay Pharmaceuticals Inc | 3.314M |
Protalix BioTherapeutics Inc | 33.57M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 9.739M |
Total Liabilities (Quarterly) | 45.02M |